PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Dalteparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- Acronyms PROTEST
Most Recent Events
- 16 Nov 2022 Planned End Date changed from 1 Dec 2023 to 1 Dec 2027.
- 16 Nov 2022 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2026.
- 15 Feb 2019 Planned number of patients changed from 1500 to 1100.